Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00698230 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy of INCB013739 Plus Metformin Compared to Metformin Alone on Glycemic Control in Type 2 Diabetics
A Phase 2 study, sponsored by Incyte Corporation.
- Completed
- Registry status
- Phase 2
- Development phase
- 302
- Enrollment target
NCT00698230 is a Phase 2 study that has completed, run by Incyte Corporation. The registered enrollment target is 302 participants.
The verdict
NCT00698230, a Phase 2 study, has completed, sponsored by Incyte Corporation.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 302 participants
- Enrollment target
Study Summary
Determine the effect of treatment with INCB013739 administered as an 'add-on' to metformin therapy in type 2 diabetic subjects on safety and tolerability and glycemic control.
Interventions
- DRUG INCB013739
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 302 participants |
| Start Date | 2008-05 |
| Est. Completion | 2009-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00698230
The ClinicalTrials.gov registry entry for NCT00698230 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 302 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Incyte Corporation, which has 239 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which INCB013739 is the first listed.
NCT00698230 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00698230 about?
NCT00698230 is a clinical study titled "Safety and Efficacy of INCB013739 Plus Metformin Compared to Metformin Alone on Glycemic Control in Type 2 Diabetics". Determine the effect of treatment with INCB013739 administered as an 'add-on' to metformin therapy in type 2 diabetic subjects on safety and tolerability and glycemic control.
What is the current status of trial NCT00698230?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 302 participants. The study started on 2008-05. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00698230?
The interventions under investigation include: INCB013739 (DRUG).
Who is sponsoring clinical trial NCT00698230?
This trial is sponsored by Incyte Corporation, which has 239 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.